Robin conditions on the Euclidean ball

Techniques are presented for calculating directly the scalar functional determinant on the Euclidean d-ball. General formulae are given for Dirichlet and Robin boundary conditions. The method involves a large mass asymptotic limit which is carried out in detail for d=2 and d=4 incidentally producing some specific summations and identities. Extensive use is made of the Watson-Kober summation formula.Comment: 36p,JyTex, misprints corrected and a section on the massive case adde

Right Handed Weak Currents in Sum Rules for Axialvector Constant Renormalization

The recent experimental results on deep inelastic polarized lepton scattering off proton, deuteron and $^{3}$He together with polari% zed neutron $\beta$-decay data are analyzed. It is shown that the problem of Ellis-Jaffe and Bjorken sum rules deficiency and the neutron paradox could be solved simultaneously by assuming the small right handed current (RHC) admixture in the weak interaction Lagrangian. The possible RHC impact on pion-nucleon $\sigma$-term and Gamow-Teller sum rule for $(p,n)$ nuclear reactions is pointed out.Comment: to be published in Phys. Rev. Lett. LaTeX, 8 pages, 21 k

Further functional determinants

Functional determinants for the scalar Laplacian on spherical caps and slices, flat balls, shells and generalised cylinders are evaluated in two, three and four dimensions using conformal techniques. Both Dirichlet and Robin boundary conditions are allowed for. Some effects of non-smooth boundaries are discussed; in particular the 3-hemiball and the 3-hemishell are considered. The edge and vertex contributions to the $C_{3/2}$ coefficient are examined.Comment: 25 p,JyTex,5 figs. on request

Chiral Multiplets of Large-N Ground State Baryons

I show that in the large-N limit the ground state baryons with helicity h fall into an ((N-2h)/4,(N+2h)/4) irreducible representation of SU(2)XSU(2). This representation determines the absolute normalization of the ground state baryon axial vector couplings at large-N. Results map precisely to (spin-flavor) SU(4) results. For instance, I find g_A =(N+2)/3. As a consequence of this multiplet structure, chiral symmetry forbids pion transitions between the ground state baryons and other baryon towers in the large-N limit.Comment: 6 pages TeX and mtexsis.te

The Overall Coefficient of the Two-loop Superstring Amplitude Using Pure Spinors

Using the results recently obtained for computing integrals over (non-minimal) pure spinor superspace, we compute the coefficient of the massless two-loop four-point amplitude from first principles. Contrasting with the mathematical difficulties in the RNS formalism where unknown normalizations of chiral determinant formulae force the two-loop coefficient to be determined only indirectly through factorization, the computation in the pure spinor formalism can be smoothly carried out.Comment: 29 pages, harvmac TeX. v2: add reference

Zero Mode and Symmetry Breaking on the Light Front

We study the zero mode and the spontaneous symmetry breaking on the light front (LF). We use the discretized light-cone quantization (DLCQ) of Maskawa-Yamawaki to treat the zero mode in a clean separation from all other modes. It is then shown that the Nambu-Goldstone (NG) phase can be realized on the trivial LF vacuum only when an explicit symmetry-breaking mass of the NG boson $m_{\pi}$ is introduced. The NG-boson zero mode integrated over the LF must exhibit singular behavior $\sim 1/m_{\pi}^2$ in the symmetric limit $m_{\pi}\to 0$, which implies that current conservation is violated at zero mode, or equivalently the LF charge is not conserved even in the symmetric limit. We demonstrate this peculiarity in a concrete model, the linear sigma model, where the role of zero-mode constraint is clarified. We further compare our result with the continuum theory. It is shown that in the continuum theory it is difficult to remove the zero mode which is not a single mode with measure zero but the accumulating point causing uncontrollable infrared singularity. A possible way out within the continuum theory is also suggested based on the ``$\nu$ theory''. We finally discuss another problem of the zero mode in the continuum theory, i.e., no-go theorem of Nakanishi-Yamawaki on the non-existence of LF quantum field theory within the framework of Wightman axioms, which remains to be a challenge for DLCQ, ``$\nu$ theory'' or any other framework of LF theory.Comment: 60 pages, the final section has been expanded. A few minor corrections; version to be published in Phys. Rev.

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Asymptotic expansions of multiplicity distributions in high-energy hadron collisions

Steepest-descent methods are used to derive asymptotic prong distributions from the assumed limiting behavior of the multiplicity moments. A short-range and a long-range correlation model are shown to be each in agreement with proton-proton data from P/sub lab/=50 to 305 GeV/c, and to be well approximated by their asymptotic forms at the highest energy. Quantitative predictions are given which may distinguish between them in experiments at the CERN Intersecting Storage Rings. (3 refs)